Pearl Therapeutics

  • Company
    • About Us
    • Pearl Milestones
    • Management Team
    • Board of Directors
    • Business Development
    • Investors
    • Careers
  • Therapeutic Areas
    • COPD/Additional Therapeutic Areas
  • Pipeline & Platform
    • Pipeline Overview
    • Products in Development
      • PT003
      • PT010
      • PT001
      • PT005
    • Proprietary Platform Technology
  • News
    • Media Inquiries
    • Press Releases
    • Upcoming and Recent Events
  • Contact
    • Contact

News

  • Media Inquiries
  • Press Releases
  • Upcoming and Recent Events

2010

February 1, 2010
Pearl Therapeutics Raises $15 Million to Advance PT003, LAMA/LABA Combination Bronchodilator for COPD, into Phase 2b Study

January 6, 2010
Pearl Therapeutics Announces Positive Results from Phase 2a Trial of Glycopyrrolate Inhalation Aerosol in Chronic Obstructive Pulmonary Disease

January 4, 2010
Pearl Therapeutics Announces Positive Results from Phase 2a Trial of Formoterol Inhalation Aerosol in Chronic Obstructive Pulmonary Disease

2009

November 23, 2009
Pearl Therapeutics Appoints Howie Rosen to Board of Directors

March 02, 2009
Pearl Therapeutics Appoints Perry Karsen as CEO

February 24, 2009
Pearl Therapeutics Secures $8 Million in Debt Financing

2008

July 02, 2008
Pearl Therapeutics Closes $18 Million Financing

2007

December 20, 2007
Pearl Therapeutics, Inc. Expands Its Senior Management Team with Top Talent in Clinical Development and Regulatory Affairs

September 04, 2007
Pearl Therapeutics Raises $15.5 Million in Private Financing


  • Contact Us
  • Site Map
  • Legal Disclaimer
  • Terms of Use

© 2009 Pearl Therapeutics Inc., Pearl and the String of Pearls design are trademarks of Pearl Therapeutics, Inc.